Skip to main content

Animations

MJFF Publications

3321 - 3330 of 8587 Results
Title
Year
  • Year
  • 2023
  • 2024
  • 2021
  • 2021
  • 2020
  • 2023
  • 2017
  • 2023
  • 2016
  • 2018
  • Summary Details
    OPEN
    Title: Brain‐Targeted Liposomes Loaded with Monoclonal Antibodies Reduce Alpha‐Synuclein Aggregation and Improve Behavioral Symptoms in Parkinson's Disease
    Journal Name: Advanced Materials
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/adma.202304654
    Citation Count: 58
  • Summary Details
    OPEN
    Title: Gait patterns during overground and virtual omnidirectional treadmill walking
    Journal Name: Journal of NeuroEngineering and Rehabilitation
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1186/s12984-023-01286-6
    Citation Count: 8
  • Summary Details
    OPEN
    Title: The PINK1—Parkin mitophagy signalling pathway is not functional in peripheral blood mononuclear cells
    Journal Name: PLOS ONE
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pone.0259903
    Citation Count: 18
  • Summary Details
    OPEN
    Title: GP2: The Global Parkinson's Genetics Program
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1002/mds.28494
    Citation Count: 129
  • Summary Details
    OPEN
    Title: The effect of LRRK2 loss-of-function variants in humans
    Journal Name: Nature Medicine
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by, cc-by
    DOI - Digital Object Identifier: 10.1038/s41591-020-0893-5
    Citation Count: 103
  • Summary Details
    OPEN
    Title: Neuroprotective actions of a fatty acid nitroalkene in Parkinson’s disease
    Journal Name: npj Parkinson's Disease
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1038/s41531-023-00502-3
    Citation Count: 8
  • Summary Details
    OPEN
    Title: Integrating Next-Generation Genomic Sequencing and Mass Spectrometry To Estimate Allele-Specific Protein Abundance in Human Brain
    Journal Name: Journal of Proteome Research
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acs.jproteome.7b00324
    Citation Count: 54
  • Summary Details
    OPEN
    Title: Explainable classification of Parkinson’s disease using deep learning trained on a large multi-center database of T1-weighted MRI datasets
    Journal Name: NeuroImage: Clinical
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.nicl.2023.103405
    Citation Count: 33
  • Summary Details
    OPEN
    Title: Benzoyl chloride derivatization with liquid chromatography–mass spectrometry for targeted metabolomics of neurochemicals in biological samples
    Journal Name: Journal of Chromatography A
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.chroma.2016.04.006
    Citation Count: 227
  • Summary Details
    OPEN
    Title: Differences in Stability, Activity and Mutation Effects Between Human and Mouse Leucine-Rich Repeat Kinase 2
    Journal Name: Neurochemical Research
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1007/s11064-018-2650-4
    Citation Count: 11
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.